Effect of Ebola Progression on Transmission and Control in Liberia

被引:61
作者
Yamin, Dan [1 ]
Gertler, Shai [1 ]
Ndeffo-Mbah, Martial L. [1 ]
Skrip, Laura A. [1 ]
Fallah, Mosoka [2 ]
Nyenswah, Tolbert G. [2 ]
Altice, Frederick L. [3 ]
Galvani, Alison P. [1 ]
机构
[1] Yale Univ, Sch Publ Hlth, New Haven, CT 06510 USA
[2] Minist Hlth & Social Welf, Monrovia 1000 10, Liberia
[3] Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06510 USA
基金
美国国家卫生研究院;
关键词
HEMORRHAGIC-FEVER; WEST-AFRICA; VIRAL LOAD; RESPONSES; DYNAMICS; OUTBREAK; CONGO; RISK;
D O I
10.7326/M14-2255
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The Ebola outbreak that is sweeping across West Africa is the largest, most volatile, and deadliest Ebola epidemic ever recorded. Liberia is the most profoundly affected country, with more than 3500 infections and 2000 deaths recorded in the past 3 months. Objective: To evaluate the contribution of disease progression and case fatality on transmission and to examine the potential for targeted interventions to eliminate the disease. Design: Stochastic transmission model that integrates epidemiologic and clinical data on incidence and case fatality, daily viral load among survivors and nonsurvivors evaluated on the basis of the 2000-2001 outbreak in Uganda, and primary data on contacts of patients with Ebola in Liberia. Setting: Montserrado County, Liberia, July to September 2014. Measurements: Ebola incidence and case-fatality records from 2014 Liberian Ministry of Health and Social Welfare. Results: The average number of secondary infections generated throughout the entire infectious period of a single infected case, R, was estimated as 1.73 (95% CI, 1.66 to 1.83). There was substantial stratification between survivors (R-Survivors), for whom the estimate was 0.66 (CI, 0.10 to 1.69), and nonsurvivors (R-Nonsurvivors), for whom the estimate was 2.36 (CI, 1.72 to 2.80). The nonsurvivors had the highest risk for transmitting the virus later in the course of disease progression. Consequently, the isolation of 75% of infected individuals in critical condition within 4 days from symptom onset has a high chance of eliminating the disease. Limitation: Projections are based on the initial dynamics of the epidemic, which may change as the outbreak and interventions evolve. Conclusion: These results underscore the importance of isolating the most severely ill patients with Ebola within the first few days of their symptomatic phase.
引用
收藏
页码:11 / U140
页数:8
相关论文
共 32 条
  • [1] ANDERSON R M, 1991
  • [2] [Anonymous], 2014, Ebola response roadmap
  • [3] [Anonymous], EBOLA OUTBREAK IN WE
  • [4] [Anonymous], 2014, PLoS Curr. Outbreaks
  • [5] Ebola Virus Disease in West Africa - The First 9 Months of the Epidemic and Forward Projections
    Aylward, Bruce
    Barboza, Philippe
    Bawo, Luke
    Bertherat, Eric
    Bilivogui, Pepe
    Blake, Isobel
    Brennan, Rick
    Briand, Sylvie
    Chakauya, Jethro Magwati
    Chitala, Kennedy
    Conteh, Roland M.
    Cori, Anne
    Croisier, Alice
    Dangou, Jean-Marie
    Diallo, Boubacar
    Donnelly, Christl A.
    Dye, Christopher
    Eckmanns, Tim
    Ferguson, Neil M.
    Formenty, Pierre
    Fuhrer, Caroline
    Fukuda, Keiji
    Garske, Tini
    Gasasira, Alex
    Gbanyan, Stephen
    Graaff, Peter
    Heleze, Emmanuel
    Jambai, Amara
    Jombart, Thibaut
    Kasolo, Francis
    Kadiobo, Albert Mbule
    Keita, Sakoba
    Kertesz, Daniel
    Kone, Moussa
    Lane, Chris
    Markoff, Jered
    Massaquoi, Moses
    Mills, Harriet
    Mulba, John Mike
    Musa, Emmanuel
    Myhre, Joel
    Nasidi, Abdusalam
    Nilles, Eric
    Nouvellet, Pierre
    Nshimirimana, Deo
    Nuttall, Isabelle
    Nyenswah, Tolbert
    Olu, Olushayo
    Pendergast, Scott
    Perea, William
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (16) : 1481 - 1495
  • [6] Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients
    Baize, S
    Leroy, EM
    Georges-Courbot, MC
    Capron, M
    Lansoud-Soukate, J
    Debré, P
    Fisher-Hoch, SP
    McCormick, JB
    McCormick, JB
    Georges, AJ
    [J]. NATURE MEDICINE, 1999, 5 (04) : 423 - 426
  • [7] Inflammatory responses in Ebola virus-infected patients
    Baize, S
    Leroy, EM
    Georges, AJ
    Georges-Courbot, MC
    Capron, M
    Bedjabaga, I
    Lansoud-Soukate, J
    Mavoungou, E
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (01) : 163 - 168
  • [8] The Ebola virus VP35 protein functions as a type IIFN antagonist
    Basler, CF
    Wang, XY
    Mühlberger, E
    Volchkov, V
    Paragas, J
    Klenk, HD
    Garcia-Sastre, A
    Palese, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) : 12289 - 12294
  • [9] Social Factors in Epidemiology
    Bauch, Chris T.
    Galvani, Alison P.
    [J]. SCIENCE, 2013, 342 (6154) : 47 - 49
  • [10] Assessment of the risk of Ebola virus transmission from bodily fluids and fomites
    Bausch, Daniel G.
    Towner, Jonathan S.
    Dowell, Scott F.
    Kaducu, Felix
    Lukwiya, Matthew
    Sanchez, Anthony
    Nichol, Stuart T.
    Ksiazek, Thomas G.
    Rollin, Pierre E.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 196 : S142 - S147